CellaVision is a Lund-based global medical technology company that develops and sells AI-powered systems for automated digital cell morphology analysis in healthcare. Its systems analyse blood and body fluid samples, replacing manual microscopy with standardized, reproducible digital imaging used in hospital labs worldwide. Listed on Nasdaq Stockholm Mid Cap, CellaVision reported SEK 759 million in sales in 2025 and employs approximately 200 people across 13 local market offices covering 40+ countries.
cellavision.comPart of: Skåne Startup map